| （単位：千ドル） | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 2,254 | 1,800 | 5,985 | 7,321 | 8,309 | 8,713 | 9,133 | 11,179 | 12,449 | 19,533 | 27,247 | 25,266 |
| 営業費用 | 3,441 | 3,935 | 9,206 | 10,411 | 11,371 | 13,135 | 13,478 | 16,039 | 17,774 | 24,381 | 32,265 | 30,370 |
| 営業利益 | -3,441 | -3,935 | -9,206 | -10,411 | -11,371 | -13,135 | -13,478 | -16,039 | -17,774 | -24,381 | -32,265 | -30,370 |
| 純利益 | -61,358 | -3,902 | -9,129 | -10,151 | -10,710 | -11,307 | -11,610 | -12,957 | -14,873 | -20,537 | -29,765 | -28,796 |
| 一株あたり利益 | - | - | - | -0.25 | -0.26 | -0.28 | -0.28 | -0.24 | -0.25 | -0.34 | -0.5 | -0.48 |
| 希薄化後一株あたり利益 | - | - | - | -0.25 | -0.26 | -0.28 | -0.28 | -0.24 | -0.25 | -0.34 | -0.5 | -0.48 |